Microbot Medical (MBOT) Shares Outstanding (Weighted Average) (2010 - 2026)

Microbot Medical has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $67.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 219902.76% year-over-year to $67.2 million; the trailing twelve-month figure through Mar 2026 stood at $67.2 million (up 219902.76% YoY), and the FY2025 full-year result was $16.3 million, up 214.17% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $67.2 million, up from $16.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $67.2 million in Q1 2026, with the low at $30526.0 in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $15.4 million across 5 years, with a median of $9.2 million in 2023.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) plunged 99.78% — and 2026, when it jumped 219902.76%.
• Microbot Medical's Shares Outstanding (Weighted Average) stood at $51125.0 in 2022, then climbed by 18.29% to $60476.0 in 2023, then surged by 8485.78% to $5.2 million in 2024, then jumped by 214.17% to $16.3 million in 2025, then jumped by 311.68% to $67.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $67.2 million (Q1 2026), $16.3 million (Q4 2025), and $48.1 million (Q3 2025), per Business Quant data.